Magnesiumsulfaat Teva

Magnesium sulfate, the active ingredient in Magnesiumsulfaat Teva, is an electrolyte/mineral supplement presented as an injection solution for intravenous use. It is employed to treat magnesium deficiency, prevent and treat eclampsia, manage severe preeclampsia, and address certain cardiac arrhythmias such as torsades de pointes.

GNH USA supplies Magnesiumsulfaat Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnesium sulfate is used in obstetric, cardiac and electrolyte‑replacement contexts.

- Eclampsia: prevents and treats seizures associated with eclampsia. - Severe preeclampsia: reduces progression to eclampsia and stabilises blood pressure. - Magnesium deficiency: restores normal serum magnesium concentrations. - Torsades de pointes: stabilises cardiac repolarisation to terminate the arrhythmia. - Bronchospasm: relaxes bronchial smooth muscle to improve airflow.

Adverse reactions to magnesium sulfate may range from mild to life‑threatening.

Common Side Effects: - Flushing: sensation of warmth and redness. - Nausea: mild gastrointestinal upset. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing effort. - Cardiac arrest: severe arrhythmia leading to loss of cardiac output. - Hypermagnesemia: excessive serum magnesium causing muscle weakness and loss of deep‑tendon reflexes.

Magnesium sulfate requires careful monitoring to avoid toxicity and interactions.

- Monitor serum magnesium levels: adjust infusion to keep within therapeutic range. - Assess renal function: impaired clearance increases risk of accumulation. - Use cautiously in myasthenia gravis: may exacerbate muscle weakness. - Avoid rapid IV bolus in patients with heart block: risk of arrhythmia. - Discontinue if signs of hypermagnesemia appear: such as loss of deep‑tendon reflexes. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium sulfate can interact with several drug classes, requiring vigilance.

Major Interactions (Avoid): - Calcium‑containing solutions: antagonistic effect reduces magnesium efficacy. - Neuromuscular blocking agents (e.g., succinylcholine, non‑depolarizing blockers): potentiated blockade leading to prolonged paralysis. - Aminoglycoside antibiotics: increased risk of neuromuscular weakness.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase urinary magnesium loss. - ACE inhibitors or ARBs: can augment hypermagnesemia. - Antihypertensives (e.g., nifedipine): additive vasodilatory effect may cause hypotension.